Malin Corporation | MLC - Net Income


Malin Corporation reported EUR-1.1M in Net Income for its fiscal semester ending in December of 2023.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -952K 54K Jun/2026
ALKERMES USD 16.29M 15.79M Sep/2026
Avita Medical AUD -7.66M 3.96M Jun/2026
Dianthus Therapeutics USD -50.22M 9.38M Jun/2026
Eurofins Scientific SE EUR 302M 108.3M Jun/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
IQVIA Holdings USD 350M 94M Sep/2026
Lonza CHF 426M 119M Jun/2025
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD 164M 56M Sep/2026
Ovoca Bio EUR 4.42M 5.19M Dec/2025
Revvity USD 62.3M 10.48M Sep/2026
Tectonic Therapeutic USD -22.28M 2.96M Jun/2026
Viatris USD -325.3M 206.5M Sep/2026
Xeris Pharmaceuticals USD -31.1M 33.34M Jun/2026